1. Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;
2. Medical Research Council (MRC) Toxicology Unit, Leicester University, Leicester, United Kingdom;
3. Division of Hematology, Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy;
4. Department of Haematology, Belfast City Hospital, Belfast, United Kingdom;
5. Department of Haematology, Aker University Hospital, University of Oslo, Oslo, Norway;
6. Royal Marsden Hospital, Sutton, United Kingdom;
7. Department of Medicine, Sydney University, Nepean Hospital, Penrith, Australia; and
8. Section of Haemato-Oncology, Institute of Cancer Research, Sutton, United Kingdom